Raptor Pharmaceutical Announces Closing of Underwritten Public Offering and Exercise in Full of Underwriters' Option to Purchase Additional Shares
08 avr. 2015 12h13 HE
|
Raptor Pharmaceutical Inc
NOVATO, Calif., April 8, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP), a biopharmaceutical company focused on developing and commercializing transformative treatments for people...
Raptor Pharmaceutical Announces Pricing of Public Offering of Common Stock
02 avr. 2015 07h00 HE
|
Raptor Pharmaceutical Inc
NOVATO, Calif., April 2, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP), a biopharmaceutical company focused on developing and commercializing transformative treatments for people...
Raptor Pharmaceutical Announces Proposed Public Offering of Common Stock
30 mars 2015 16h20 HE
|
Raptor Pharmaceutical Inc
NOVATO, Calif., March 30, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP), a biopharmaceutical company focused on developing and commercializing transformative treatments for people...
Raptor Pharmaceutical Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
11 mars 2015 16h05 HE
|
Raptor Pharmaceutical Inc
NOVATO, Calif., March 11, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that on March 9, 2015, the Compensation Committee of the Company's Board of Directors...
Raptor Pharmaceutical to Observe International Rare Disease Day Through Global Awareness Programs
23 févr. 2015 08h00 HE
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Feb. 23, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced its support of Rare Disease Day on February 28, 2015 with a series of initiatives and events...
Raptor Pharmaceutical to Attend Upcoming Investor Conferences
18 févr. 2015 08h00 HE
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Feb. 18, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that Michael Smith, Chief Financial Officer will participate in the following investor...
Raptor Pharmaceutical to Hold Fourth Quarter and Full Year 2014 Financial Results Conference Call and Webcast on Thursday, February 26, 2015 at 4:30 p.m. ET
17 févr. 2015 08h00 HE
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Feb. 17, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that the company will release fourth quarter and full year 2014 financial results on...
PROCYSBI(R) to Receive New Treatment Award From Lysosomal Disease Network at the 11th Annual WORLD Symposium
10 févr. 2015 09h51 HE
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Feb. 10, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that the Lysosomal Disease Network (LDN) will present Raptor Pharmaceutical with the 2015...
Raptor Pharmaceutical to Present at the 2015 Leerink Global Healthcare Conference
30 janv. 2015 13h30 HE
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Jan. 30, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that it will present at the following conference:
Julie Anne Smith, President and Chief...
Raptor Pharmaceutical Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
20 janv. 2015 08h00 HE
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Jan. 20, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that on January 15, 2015, a majority of the independent members of the Company's Board of...